https://www.avient.com/sites/default/files/2020-09/gravi-tech-processing-guide-chinese.pdf
05 Gravi-Tech_High-Density_Compounds_Processing_Guide Chinese-20191121 Gravi-Tech™ 高密度改性配方 加工指南 GRAVI-TECH™ 密度改性配方 注塑成型参数 TBPAPSBA 料筒温度 °F (°C) 后段 400–475 (200–250) 480-540 (248-282) 480–520 (250–270) 中段 410–480 (205–253) 490-550 (254-287) 485-525 (251-273) 前段 420–490 (210–257) 500-560 (260-293) 490-530 (254-276) 喷嘴 425–500 (215–260) 510-570 (265-298) 490-540 (254-282) 熔体温度 425–515 (215–270) 510-570 (265-298) 490-540 (254-282) 模具温度 140–200 (60–90) 150-300 (65-148) 140-280 (60-137) 干燥参数 190 (90) 2–4 小时 0.01%–0.15% 180 (82) 4–5 小时 0.10%–0.20% 275 (135) 3–4 小时 0.02%–0.04% 喷嘴类型 注塑压力 背压 螺杆转速 缓冲料垫 通用 尼龙或倒锥形 通用 注塑速度 1 2 – 5 in/sec; 50 - 127 mm/sec 中压至高压(范围可能为1,000-4,000 psi; 7-28 Mpa) 50-100 psi; 0.3-0.7 Mpa 25–75 RPM 0.125 - 0.250 in; 3 - 6 mm 螺杆压缩比2 2.0:1–2.5:1 2 Gravi-Tech Gravi-Tech™聚合物金属复合材料属于高密度材料, 是铅和其他传统金属的热塑性替代材料。
加工指南 7 翘曲 取向过度 模具设计 模具设计 1.
https://www.avient.com/sites/default/files/2024-08/AVNT Second Quarter Earnings Press Release.pdf
Rose
Vice President, Marketing and Communications
Avient Corporation
+1 440-930-3162
kyle.rose@avient.com
7
Attachment 1
Avient Corporation
Summary of Condensed Consolidated Statements of Income (Unaudited)
(In millions, except per share data)
Three Months Ended
June 30,
Six Months Ended
June 30,
2024 2023 2024 2023
Sales $ 849.7 $ 824.4 $ 1,678.7 $ 1,670.1
Operating Income 72.5 62.3 166.5 119.4
Net income from continuing operations attributable to Avient
shareholders 33.6 22.1 83.0 42.9
Diluted earnings per share from continuing operations attributable to
Avient shareholders $ 0.36 $ 0.24 $ 0.90 $ 0.47
Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders
and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special
items, to assess performance and facilitate comparability of results.
Three Months Ended
June 30,
Six Months Ended
June 30,
2024 2023 2024 2023
Sales:
Color, Additives and Inks $ 542.0 $ 524.5 $ 1,057.3 $ 1,061.5
Specialty Engineered Materials 308.1 300.8 622.5 610.5
Corporate (0.4) (0.9) (1.1) (1.9)
Sales $ 849.7 $ 824.4 $ 1,678.7 $ 1,670.1
Gross margin:
Color, Additives and Inks $ 184.5 $ 164.1 $ 355.7 $ 326.1
Specialty Engineered Materials 94.7 91.5 201.7 185.4
Corporate (21.6) (14.9) (21.6) (23.2)
Gross margin $ 257.6 $ 240.7 $ 535.8 $ 488.3
Selling and administrative expense:
Color, Additives and Inks $ 98.4 $ 96.1 $ 194.8 $ 192.5
Specialty Engineered Materials 51.9 51.8 105.5 102.6
Corporate 34.8 30.5 69.0 73.8
Selling and administrative expense $ 185.1 $ 178.4 $ 369.3 $ 368.9
Operating income:
Color, Additives and Inks $ 86.1 $ 68.0 $ 160.9 $ 133.6
Specialty Engineered Materials 42.8 39.7 96.2 82.8
Corporate (56.4) (45.4) (90.6) (97.0)
Operating income $ 72.5 $ 62.3 $ 166.5 $ 119.4
Depreciation & amortization:
Color, Additives and Inks $ 21.8 $ 25.7 $ 43.7 $ 51.5
Specialty Engineered Materials 20.8 19.9 40.4 41.1
Corporate 2.3 2.0 5.1 5.5
Depreciation & amortization $ 44.9 $ 47.6 $ 89.2 $ 98.1
Earnings before interest, taxes, depreciation and
amortization (EBITDA):
Color, Additives and Inks $ 107.9 $ 93.7 $ 204.6 $ 185.1
Specialty Engineered Materials 63.6 59.6 136.6 123.9
Corporate (54.1) (43.4) (85.5) (91.5)
Other (expense) income, net (0.9) (0.2) (1.8) 0.5
EBITDA from continuing operations $ 116.5 $ 109.7 $ 253.9 $ 218.0
Special items, before tax 28.1 21.7 34.3 49.0
Interest expense included in special items (1.0) — (1.0) —
Depreciation & amortization included in special items (0.3) (0.1) (0.8) (1.9)
Adjusted EBITDA $ 143.3 $ 131.3 $ 286.4 $ 265.1
13
Attachment 7
Avient Corporation
Reconciliation of Non-GAAP Financial Measures (Unaudited)
(In millions, except per share data)
Senior management uses gross margin before special items and operating income before special items to assess performance
and allocate resources because senior management believes that these measures are useful in understanding current
profitability levels and how it may serve as a basis for future performance.